Clover Biopharmaceuticals, Ltd. (HKG:2197)
Hong Kong · Delayed Price · Currency is HKD 2.200
-0.230 (-9.47%)
May 28, 2026, 11:57 AM HKT
Clover Biopharmaceuticals Market Cap
Clover Biopharmaceuticals has a market cap or net worth of 3.15 billion as of May 27, 2026. Its market cap has increased by 1,069.15% in one year.
Market Cap
3.15B
Enterprise Value
2.85B
Revenue
3.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.20
Market Cap Chart
Since November 5, 2021, Clover Biopharmaceuticals's market cap has decreased from 15.03B to 3.15B, a decrease of -79.02%. That is a compound annual growth rate of -29.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 3.15B | 3.86% |
| Dec 31, 2025 | 3.04B | 871.54% |
| Dec 31, 2024 | 312.59M | -61.08% |
| Dec 29, 2023 | 803.26M | -76.01% |
| Dec 30, 2022 | 3.35B | -78.71% |
| Dec 31, 2021 | 15.73B | 4.62% |
| Nov 5, 2021 | 15.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shandong Boan Biotechnology | 3.73B |
| Mirxes Holding Company | 3.66B |
| Qyuns Therapeutics | 3.66B |
| PegBio | 3.45B |
| TYK Medicines | 3.44B |
| BioDlink International Company | 3.27B |
| Jiangsu Recbio Technology | 3.08B |
| Medtide | 3.05B |